Kiran Kanneganti

Kiran Kanneganti has had an extensive career in the pharmaceutical industry. Starting in 2001 at Dr. Reddy's Laboratories as a Research Scientist, Kanneganti then moved on to Lupin Pharmaceuticals where they worked as a Senior Formulation Scientist. In 2004, they joined InvaGen Pharmaceuticals Inc, initially as a Senior Formulation Scientist, then later as Manager and Associate Director of Product Development. In 2017, Kanneganti became the Director of Product Development at InvaGen Pharmaceuticals (A Cipla Subsidiary). Kiran then joined Chartwell Pharmaceuticals in 2018, first as a Director of R&D and Technical Services, then as Vice President, and currently holds the position of Senior Vice President in the same department.

Kiran Kanneganti has a degree in M.Pharm in Pharmaceuticals from Andhra University. Additionally, they have studied Project Management at Rutgers Business School and Copyright and Patent law at Seton Hall University School of Law. The exact start and end years for each education program are not provided.